Vaccine Protection Assay
    1.
    发明申请
    Vaccine Protection Assay 有权
    疫苗保护测定

    公开(公告)号:US20080064057A1

    公开(公告)日:2008-03-13

    申请号:US11469204

    申请日:2006-08-31

    IPC分类号: C12Q1/18

    摘要: The present invention relates to the field of Serum Bactericidal Activity (SBA) assays for Gram negative bacteria, in particular N. meningitidis. The SBA assay is the most important method for measuring functional activity of serum antibodies against meningococcus. In order to determine whether a subject or a population is seropositive against invasive meningococcus the SBA test should ideally be both sensitive and specific. The inventors have found the standard N. meningitidis serotype A and W SBAs can be significantly improved in this regard.

    摘要翻译: 本发明涉及革兰氏阴性细菌,特别是脑膜炎奈瑟氏球菌的血清杀菌活性(SBA)测定领域。 SBA测定法是测定脑膜炎球菌血清抗体功能活性的最重要方法。 为了确定受试者或群体是否对侵袭性脑膜炎球菌血清阳性,SBA测试应理想地是敏感和特异性的。 本发明人已经发现,在这方面可以显着改善脑膜炎奈瑟氏球菌血清型A和W SBA。